A detailed history of Ranger Investment Management, L.P. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Ranger Investment Management, L.P. holds 589,688 shares of ANIP stock, worth $31.5 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares
589,688
Previous 402,734 46.42%
Holding current value
$31.5 Million
Previous $25.6 Million 37.18%
% of portfolio
2.32%
Previous 1.79%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$54.33 - $65.72 $10.2 Million - $12.3 Million
186,954 Added 46.42%
589,688 $35.2 Million
Q2 2024

Aug 14, 2024

BUY
$58.53 - $68.82 $31,020 - $36,474
530 Added 0.13%
402,734 $25.6 Million
Q1 2024

May 15, 2024

SELL
$54.2 - $69.69 $1.76 Million - $2.26 Million
-32,413 Reduced 7.46%
402,204 $27.8 Million
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $378,505 - $508,325
7,769 Added 1.82%
434,617 $24 Million
Q3 2023

Nov 14, 2023

SELL
$50.28 - $64.61 $920,576 - $1.18 Million
-18,309 Reduced 4.11%
426,848 $24.8 Million
Q2 2023

Aug 14, 2023

BUY
$37.29 - $53.83 $11.9 Million - $17.2 Million
319,601 Added 254.55%
445,157 $24 Million
Q1 2023

May 05, 2023

BUY
$37.61 - $45.72 $164,355 - $199,796
4,370 Added 3.61%
125,556 $4.99 Million
Q4 2022

Feb 14, 2023

BUY
$31.9 - $41.95 $85,364 - $112,258
2,676 Added 2.26%
121,186 $4.88 Million
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $63,567 - $80,999
-2,131 Reduced 1.77%
118,510 $3.81 Million
Q2 2022

Aug 15, 2022

BUY
$23.09 - $33.46 $65,575 - $95,026
2,840 Added 2.41%
120,641 $3.58 Million
Q1 2022

May 13, 2022

BUY
$26.91 - $47.15 $189,715 - $332,407
7,050 Added 6.37%
117,801 $3.31 Million
Q4 2021

Feb 11, 2022

BUY
$32.97 - $56.85 $824 - $1,421
25 Added 0.02%
110,751 $5.1 Million
Q3 2021

Nov 15, 2021

BUY
$26.48 - $35.99 $153,186 - $208,202
5,785 Added 5.51%
110,726 $3.63 Million
Q2 2021

Aug 16, 2021

SELL
$31.86 - $38.6 $14,018 - $16,984
-440 Reduced 0.42%
104,941 $3.68 Million
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $40,356 - $51,354
-1,421 Reduced 1.33%
105,381 $3.81 Million
Q4 2020

Feb 12, 2021

SELL
$23.69 - $31.47 $425,496 - $565,232
-17,961 Reduced 14.4%
106,802 $3.1 Million
Q3 2020

Nov 16, 2020

BUY
$26.38 - $33.1 $1.46 Million - $1.84 Million
55,527 Added 80.2%
124,763 $3.52 Million
Q2 2020

Aug 14, 2020

SELL
$29.93 - $50.1 $834,298 - $1.4 Million
-27,875 Reduced 28.7%
69,236 $2.24 Million
Q1 2020

May 15, 2020

BUY
$30.35 - $67.14 $205,530 - $454,672
6,772 Added 7.5%
97,111 $3.96 Million
Q4 2019

Feb 14, 2020

SELL
$55.65 - $79.83 $185,036 - $265,434
-3,325 Reduced 3.55%
90,339 $5.57 Million
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $228,002 - $300,914
3,524 Added 3.91%
93,664 $6.83 Million
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $245,530 - $297,810
3,623 Added 4.19%
90,140 $7.41 Million
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $305,456 - $470,149
6,665 Added 8.35%
86,517 $6.1 Million
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $396,878 - $544,081
9,640 Added 13.73%
79,852 $3.6 Million
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $540,725 - $728,524
10,212 Added 17.02%
70,212 $3.97 Million
Q2 2018

Aug 14, 2018

BUY
$56.38 - $68.08 $607,945 - $734,106
10,783 Added 21.91%
60,000 $4.01 Million
Q1 2018

May 15, 2018

BUY
$56.98 - $72.41 $554,415 - $704,549
9,730 Added 24.64%
49,217 $2.87 Million
Q4 2017

Feb 13, 2018

BUY
$53.3 - $74.56 $138,206 - $193,334
2,593 Added 7.03%
39,487 $2.55 Million
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $1.6 Million - $1.94 Million
36,894
36,894 $1.94 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $930M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Ranger Investment Management, L.P. Portfolio

Follow Ranger Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranger Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ranger Investment Management, L.P. with notifications on news.